Literature DB >> 16862255

Aripiprazole therapy for nicotine dependence.

Sriram Ramaswamy1, Subhash C Bhatia.   

Abstract

Entities:  

Year:  2006        PMID： 16862255      PMCID： PMC1510913          DOI： 10.4088/pcc.v08n0109b

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  16 in total

1.  Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, "Goldilocks" actions at dopamine receptors.

Authors:  S M Stahl
Journal:  J Clin Psychiatry       Date:  2001-11       Impact factor: 4.384

2.  Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action.

Authors:  S M Stahl
Journal:  J Clin Psychiatry       Date:  2001-12       Impact factor: 4.384

3.  Tobacco withdrawal in self-quitters.

Authors:  J R Hughes
Journal:  J Consult Clin Psychol       Date:  1992-10

4.  Modulating tobacco smoking rates by dopaminergic stimulation and blockade.

Authors:  Nicholas H Caskey; Murray E Jarvik; William C Wirshing; Damian C Madsen; Paula N Iwamoto-Schaap; Naomi I Eisenberger; Lorena Huerta; Scott M Terrace; Richard E Olmstead
Journal:  Nicotine Tob Res       Date:  2002-08       Impact factor: 4.244

5.  The effects of dopaminergic D2 stimulation and blockade on smoking behavior.

Authors:  N H Caskey; M E Jarvik; W C Wirshing
Journal:  Exp Clin Psychopharmacol       Date:  1999-02       Impact factor: 3.157

6.  Aripiprazole reduces alcohol use.

Authors:  Mustafa Warsi; S Pirzada Sattar; Subhash C Bhatia; Frederick Petty
Journal:  Can J Psychiatry       Date:  2005-03       Impact factor: 4.356

7.  A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients.

Authors:  A Margolin; T R Kosten; S K Avants; J Wilkins; W Ling; M Beckson; I O Arndt; J Cornish; J A Ascher; S H Li
Journal:  Drug Alcohol Depend       Date:  1995-12       Impact factor: 4.492

8.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

Review 9.  Dopamine in drug abuse and addiction: results from imaging studies and treatment implications.

Authors:  N D Volkow; J S Fowler; G-J Wang; J M Swanson
Journal:  Mol Psychiatry       Date:  2004-06       Impact factor: 15.992

Review 10.  Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability.

Authors:  Anthony DeLeon; Nick C Patel; M Lynn Crismon
Journal:  Clin Ther       Date:  2004-05       Impact factor: 3.393
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.